Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
36M
-
Shares change
-
+896K
-
Total reported value, excl. options
-
$638M
-
Value change
-
+$14.3M
-
Put/Call ratio
-
0.31
-
Number of buys
-
64
-
Number of sells
-
-81
-
Price
-
$17.72
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q2 2022
171 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q2 2022.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36M shares
.
Largest 10 shareholders include BlackRock Inc. (5.65M shares), Rubric Capital Management LP (3.26M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), VANGUARD GROUP INC (2.27M shares), JANUS HENDERSON GROUP PLC (2.21M shares), PRINCIPAL FINANCIAL GROUP INC (1.74M shares), RENAISSANCE TECHNOLOGIES LLC (1.4M shares), STATE STREET CORP (1.39M shares), Camber Capital Management LP (1.05M shares), and Invesco Ltd. (1.01M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.